Because active PPARγ can decrease iNOS expression, and iNOS production is linked to inflammatory and environmental variables that increase lung cancer risk, this difference in the expression pattern could be attributed to NSCLC etiology [150]. The gene discussed is PPARG; the disease is lung cancer.